Breast cancer risk associated with hormone replacement therapy has been underestimated

Risk of breast cancer in women taking combined menopausal hormone therapy is three times higher than in non-users, study finds.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research